Correlation Between Eliem Therapeutics and Psyence Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Psyence Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Psyence Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Psyence Biomedical Ltd, you can compare the effects of market volatilities on Eliem Therapeutics and Psyence Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Psyence Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Psyence Biomedical.

Diversification Opportunities for Eliem Therapeutics and Psyence Biomedical

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eliem and Psyence is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Psyence Biomedical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Psyence Biomedical and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Psyence Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Psyence Biomedical has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Psyence Biomedical go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Psyence Biomedical

Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.79 times more return on investment than Psyence Biomedical. However, Eliem Therapeutics is 1.26 times less risky than Psyence Biomedical. It trades about 0.04 of its potential returns per unit of risk. Psyence Biomedical Ltd is currently generating about -0.09 per unit of risk. If you would invest  255.00  in Eliem Therapeutics on September 2, 2024 and sell it today you would earn a total of  49.00  from holding Eliem Therapeutics or generate 19.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

Eliem Therapeutics  vs.  Psyence Biomedical Ltd

 Performance 
       Timeline  
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Psyence Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Psyence Biomedical Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Eliem Therapeutics and Psyence Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eliem Therapeutics and Psyence Biomedical

The main advantage of trading using opposite Eliem Therapeutics and Psyence Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Psyence Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psyence Biomedical will offset losses from the drop in Psyence Biomedical's long position.
The idea behind Eliem Therapeutics and Psyence Biomedical Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Correlations
Find global opportunities by holding instruments from different markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk